A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...
A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...
Five years ago, a group of high-risk skin cancer patients received a bespoke vaccine. The data is finally in, and the results ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...
In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...
A researcher at the IU Indianapolis Fairbanks School of Public Health has identified a set of novel biomarkers that could ...
By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized ...
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their immune systems to help fight tumors. People with advanced lung or skin ...